Research Articles | Page 2 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Management of myelodysplastic syndromes after failure of response to hypomethylating agents May 2019 Therapeutic Advances in Hematology Myelodysplastic Syndromes (MDS)
Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators Dec 2024 Therapeutic Advances in Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes Apr 2023 The Oncologist Myelodysplastic Syndromes (MDS)
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes Apr 2023 The Oncologist Myelodysplastic Syndromes (MDS)
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Mar 2021 The New England Journal of Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)
Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria Jun 2024 The New England Journal of Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)
Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria Jun 2024 The New England Journal of Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)
Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria. Reply Jun 2024 The New England Journal of Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Jan 2020 The New England Journal of Medicine Myelodysplastic Syndromes (MDS)
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria Mar 2024 The New England Journal of Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)